Evidence map›Paper›PMID 37852252›Full record

ArticleDevelopmental cell2023

Proteomic profiling of centrosomes across multiple mammalian cell and tissue types by an affinity capture method.

Sarah Carden, Elisa Vitiello, Ivan Rosa E Silva, James Holder, Valentina Quarantotti, Kamal Kishore, Valar Nila Roamio Franklin, Clive D'Santos, Takashi Ochi, Mark van Breugel and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Developmental cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Isolation of Mitotic Centrosomes from Cultured Human Cells.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Sarah CardenCRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
Elisa VitielloDepartment of Biochemistry, University of Oxford, Oxford, UK.
Ivan Rosa E SilvaMRC Laboratory of Molecular Biology, Cambridge, UK.
James HolderDepartment of Biochemistry, University of Oxford, Oxford, UK.
Valentina QuarantottiCRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
Kamal KishoreCRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
Valar Nila Roamio FranklinCRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
Clive D'SantosCRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
Takashi OchiMRC Laboratory of Molecular Biology, Cambridge, UK; The Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, University of Leeds, Leeds, UK. Electronic address: t.ochi@leeds.ac.uk.
Mark van BreugelMRC Laboratory of Molecular Biology, Cambridge, UK; School of Biological & Behavioural Sciences, Queen Mary University of London, London, UK. Electronic address: m.vanbreugel@qmul.ac.uk.
Fanni GergelyCRUK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Department of Biochemistry, University of Oxford, Oxford, UK. Electronic address: fanni.gergely@bioch.ox.ac.uk.
University of Cambridge · GBUniversity of Oxford · GBMRC Laboratory of Molecular Biology · GBQueen Mary University of London · GBUniversity of Leeds · GB

Funding

Biotechnology and Biological Sciences Research Council BB/V003577/1Cancer Research UK 17043Cancer Research UK 24455Cancer Research UK A24455Cancer Research UK C14303/A17197Cancer Research UK CRI_CORE_BIOIN_2324Cancer Research UK CRI_CORE_PROTE_2324Medical Research Council MC_UP_1201/3Wellcome TrustWellcome Trust 108466/Z/15/Z
6 · The paper itself

Abstract

Centrosomes are the major microtubule-organizing centers in animals and play fundamental roles in many cellular processes. Understanding how their composition varies across diverse cell types and how it is altered in disease are major unresolved questions, yet currently available centrosome isolation protocols are cumbersome and time-consuming, and they lack scalability. Here, we report the development of centrosome affinity capture (CAPture)-mass spectrometry (MS), a powerful one-step purification method to obtain high-resolution centrosome proteomes from mammalian cells. Utilizing a synthetic peptide derived from CCDC61 protein, CAPture specifically isolates intact centrosomes. Importantly, as a bead-based affinity method, it enables rapid sample processing and multiplexing unlike conventional approaches. Our study demonstrates the power of CAPture-MS to elucidate cell-type-dependent heterogeneity in centrosome composition, dissect hierarchical interactions, and identify previously unknown centrosome components. Overall, CAPture-MS represents a transformative tool to unveil temporal, regulatory, cell-type- and tissue-specific changes in centrosome proteomes in health and disease.

Indexed as

ProteomeProteomicsAnimalsCentrosomeMammalsMicrotubule-Organizing CenterMicrotubulesProteomeappendageBasal bodycentriolecentrosomal proteinscentrosomeciliamass spectrometryproteometissue-specific

Identifiers

PMID37852252
PMCPMC7618310
OpenAlexW4387709205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.